Purchase Order 75N91019P00822
Award Date 9/17/19
Potential Completion Date 10/17/19
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Denville, NJ 07834, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Diagenode, LLC for a Bioruptor Plus instrument (catalog B01020002) for 1.5 and 15 mL tubes, valued at $23,300, on August 21, 2018. No small business set-aside applied. Performance occurs at Denville, New Jersey. The order carries a firm fixed price and an ultimate completion date of October 31, 2018.</p>
- <p>The National Cancer Institute awarded a purchase order to Diagenode, LLC for $4,750.00 on August 16, 2017, for parts replacement, calibration, and service repair of a Bioruptor instrument used for DNA and chromatin shearing. Place of performance is Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of September 15, 2017. No small business set-aside was used.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Diagenode, LLC for $23,074.00 on September 8, 2020. The order, issued under firm fixed-price terms with no small business set-aside, procures a Bioruptor Plus ultrasonic sonication device equipped with a soundproof box, water cooler, single cycle valve, and 1.5 mL tube holder. Place of performance is Belgium. The order was completed by October 8, 2020.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order contract to Diagenode, LLC for the procurement of one Diagenode Bioruptor Plus Tabletop Bath Sonicator. The contract includes the trade-in of an existing Diagenode Bioruptor Sonicator model UCD200, delivery and installation of the new equipment in Belgium, and a minimum 12-month warranty. The sonicator will support various research processes at NCI...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order to Diagenode, LLC, a global life sciences company specializing in epigenetics research and laboratory services, for the procurement of a Bioruptor PICO sonication device. The $24,991.50 contract does not have a set-aside designation and was awarded on August 6, 2020, with a completion date of September 5, 2020. Diagenode, LLC is headquartered in Denville, New Jersey and has a...
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Diagenode, LLC for a Diagenode Bioruptor Pico Sonication System valued at $25,275.50, awarded September 24, 2020, with completion by November 30, 2020. No set-aside was applied. Performance occurs in Denville, New Jersey. The order procures an ultrasonic sonication device for laboratory research applications, delivered on a firm fixed-price basis.</p>
- <p>The National Institutes of Health awarded a purchase order to Diagenode, LLC for an XL-2006 TM Bioruptor XL with accessories for 24×1.5 ml tubes, valued at $16,176.00, on September 29, 2009. Place of performance is Baltimore, Maryland. The order was completed by October 28, 2009.</p>
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Diagenode, LLC for $24,617.75 on September 22, 2019, for a Bioruptor Pico System. Place of performance is Denville, New Jersey. The order carries firm fixed-price pricing with an ultimate completion date of October 22, 2019.</p>
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Diagenode, LLC for $25,021.50 on September 14, 2018, for a Bioruptor Pico and cooler system. Place of performance is Denville, New Jersey. The order carries firm fixed-price pricing with an ultimate completion date of November 5, 2018.</p>
- The National Cancer Institute (NCI) awarded a $23,969.15 firm-fixed-price purchase order to Diagenode, LLC, a global life sciences company specializing in epigenetics research. The contract is for the delivery of a Bioruptor PLUS sonication device, which is used for DNA shearing in chromatin immunoprecipitation (ChIP) workflows. Diagenode has secured numerous federal contracts from agencies such as the National Institutes of Health (NIH), Environmental Protection Agency (EPA), and U.S....
The National Cancer Institute awarded a purchase order to Diagenode, LLC for a Bioruptor Plus Water Bath Sonicator valued at $24,809.00 on September 17, 2019. The order carries no small business set-aside. Place of performance is Denville, New Jersey. The contract is firm fixed price with an ultimate completion date of October 17, 2019.
Generated 8/1/26, 10:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 9/16/19 |